EFFECTS OF DIETARY PURIFIED EICOSAPENTAENOIC ACID (20/5(N-3)) AND DOCOSAHEXAENOIC ACID (22/6(N-3)) ON FATTY-ACID DESATURATION AND OXIDATION IN ISOLATED RAT-LIVER CELLS

被引:74
|
作者
GRONN, M
CHRISTENSEN, E
HAGVE, TA
CHRISTOPHERSEN, BO
机构
[1] NATL HOSP NORWAY, LIPID CLIN, OSLO 1, NORWAY
[2] UNIV OSLO, INST CLIN BIOCHEM, OSLO 3, NORWAY
关键词
FATTY ACID OXIDATION; DESATURASE; DELTA-5-; DELTA-6-; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; (RAT HEPATOCYTE);
D O I
10.1016/0005-2760(92)90152-L
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of dietary supplementation of eicosapentaenoic acid (20:5(n - 3), EPA) and docosahexaenoic acid (22:6(n - 3), DHA) on the metabolism of polyunsaturated fatty acids were studied in isolated rat liver cells. Both pure EPA and pure DHA and a mixture of the two n - 3 fatty acids in different doses were used. The supplementation of moderate amounts of n - 3 fatty acids suppressed the activity of DELTA-6-desaturase (50%) and to a smaller extent of the DELTA-5-desaturase (60-70%) compared to controls. When higher doses of dietary purified EPA and DHA were used, this inhibitory effect on the DELTA-6- and DELTA-5-desaturase activities disappeared. The DELTA-4-desaturase activity seemed to be unaffected by the feeding conditions used. The supplementation of the n - 3 fatty acids in the diet at all dose levels used increased the beta-oxidation of all the polyunsaturated fatty acids, especially of linoleic acid, linolenic acid and eicosapentaenoic acid. The results suggest an increase both in peroxisomal and mitochondrial beta-oxidation. The peroxisomal beta-oxidation of n - 3 fatty acids seemed to be particularly increased.
引用
收藏
页码:35 / 43
页数:9
相关论文
共 50 条
  • [41] The Myristic Acid:Docosahexaenoic Acid Ratio Versus the n-6 Polyunsaturated Fatty Acid:n-3 Polyunsaturated Fatty Acid Ratio as Nonalcoholic Fatty Liver Disease Biomarkers
    Antunes, Marina Masetto
    Godoy, Guilherme
    Curi, Rui
    Visentainer, Jesui Vergilio
    Bazotte, Roberto Barbosa
    METABOLIC SYNDROME AND RELATED DISORDERS, 2022, 20 (02) : 69 - 78
  • [42] Dietary n-6 and n-3 fatty acid balance and cardiovascular health
    Wijendran, V
    Hayes, KC
    ANNUAL REVIEW OF NUTRITION, 2004, 24 : 597 - 615
  • [43] Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid in bovine retinal microvessels
    Lecomte, M
    Paget, C
    Ruggiero, D
    Wiernsperger, N
    Lagarde, M
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 (05) : 2160 - 2167
  • [44] Triglyceride-lowering effect of n-3 long chain polyunsaturated fatty acid: eicosapentaenoic acid vs. docosahexaenoic acid
    Weber, P.
    Lipids, 34 (SUPPL.):
  • [45] Dietary effects of n-6:n-3 polyunsaturated fatty acid ratios on the antioxidant status of the liver in goslings
    Wang, M. Z.
    Ding, L. Y.
    Wang, J. F.
    Yu, L. H.
    Wang, H. R.
    JOURNAL OF ANIMAL AND FEED SCIENCES, 2012, 21 (02): : 372 - 382
  • [46] Triglyceride-lowering effect of n-3 long chain polyunsaturated fatty acid: Eicosapentaenoic acid vs. docosahexaenoic acid
    Weber, P
    LIPIDS, 1999, 34 : S269 - S269
  • [47] EFFECTS OF EICOSAPENTAENOIC ACID (20-5,N-3) ON SECRETION OF LIPOPROTEINS IN CACO-2 CELLS
    RANHEIM, T
    RUSTAN, AC
    DREVON, CA
    ARTERIOSCLEROSIS, 1990, 10 (05): : A850 - A850
  • [48] Maternal Dietary Docosahexaenoic Acid Alters Lipid Peroxidation Products and (n-3)/(n-6) Fatty Acid Balance in Offspring Mice
    Yang, Bo
    Li, Runting
    Woo, Taeseon
    Browning, Jimmy D., Jr.
    Song, Hailong
    Gu, Zezong
    Cui, Jiankun
    Lee, James C.
    Fritsche, Kevin L.
    Beversdorf, David Q.
    Sun, Grace Y.
    Greenlief, C. Michael
    METABOLITES, 2019, 9 (03):
  • [49] DEVELOPMENTAL MATURATION OF HEPATIC N-3 POLYUNSATURATED FATTY-ACID METABOLISM - SUPPLY OF DOCOSAHEXAENOIC ACID TO RETINA AND BRAIN
    MARTIN, RE
    DETURCO, EBR
    BAZAN, NG
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 1994, 5 (03): : 151 - 160
  • [50] DIETARY INDUCED LONG LASTING ACCUMULATION OF 22-6 N-3 FATTY-ACID IN RAT-BRAIN SYNAPTOSOMAL PHOSPHOLIPIDS
    GALLI, C
    PRZEGALINSKI, E
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1973, 5 (03): : 239 - 248